Assistant Professor, Medicine, University of Pittsburgh School of Medicine

Pulmonology

Dr. Daniel J. Kass is an expert in the field of Pulmonology. He researched medicine at NYU School of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Daniel J. Kass, MD is a published doctor. He has 12 papers published. The most current publication "Micromanaging microRNAs: using murine models to study microRNAs in lung fibrosis." Daniel Kass accepts all Medicare patients.

Publications

---

• Matrix Metalloproteinase-19 Promotes Metastatic Behavior In Vitro and is Associated with Increased Mortality in Non-small Cell Lung Cancer.
• C-X-C Motif Chemokine 13 (CXCL13) is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis.
• Plasma B lymphocyte stimulator and B cell differentiation in idiopathic Pulmonary fibrosis patients.
• Idiopathic Pulmonary Fibrosis Patients With Antibodies to Heat Shock Protein 70 Have Poor Prognoses.
• Matrix metalloproteinase-19 is a key regulator of Lung fibrosis in mice and humans.
• Cytokine-Like Factor 1 Gene Expression Is Enriched in Idiopathic Pulmonary Fibrosis and Drives the Accumulation of CD4(+) T Cells in Murine Lungs: Evidence for an Anti...
• Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary hypertension in monocrotaline-injured rats.
• Evolving genomic approaches to idiopathic Pulmonary fibrosis: moving beyond genes.
• Cytokine-like factor 1 (CLF1): Life after development?
• Micromanaging microRNAs: using murine models to study microRNAs in Lung fibrosis.
• Autoreactivity to glucose regulated protein 78 links Emphysema and osteoporosis in smokers.

Schools

---

• New York University

• Ny and Presby Hospital

Procedures Preformed

---

• Bronchoscopy
• Thoracentesis
• Ventilation Management

Conditions Treated

---

• Acidosis
• Alkalosis
• Asthma
• Bird Flu
• View All

Doctors Specialties

---

• Critical Care Medicine
• Pulmonology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification

Education

---

• New York Presbyterian Hospital
• NYU School of Medicine

Hospital

---

• UPMC Presbyterian Shadyside

Drug Facts

---

NPI NUMBER		1629176995
NPPES Provider LastName		KASS
NPPES Provider FirstName		DANIEL
NPPES Provider ZIPCode		152133236
NPPES Provider State		PA
Specialty Description		Pulmonary Disease
Total Claim Count		262.0
Distinct Opioid Count		1.0
Opioid Claim Count		11.0
Percent Opioid Claims		4.2

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1629176995
Last Name Of The Provider	KASS
First Name Of The Provider	DANIEL
View All

Similar Doctors

---

	Dr. Matthew J. Synan, MD This Doctor is OpenDoctor Recommended.
	Dr. Mitchell J. Patti, MD This Doctor is OpenDoctor Recommended.
	Dr. John F. McDyer, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Sally E. Wenzel, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Omer A. Bajwa, MD This Doctor is OpenDoctor Recommended.
	Dr. Subbarao Elapavaluru, MD This Doctor is OpenDoctor Recommended.
	Dr. Naveed Hasan, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven L. Orebaugh, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Bryan J. McVerry, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Harry S. Rafkin, MD This Doctor is OpenDoctor Recommended.
	Dr. Luis A. Ortiz, MD
	Dr. Frank C. Sciurba, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. John P. Williams, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael C. Reade, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog